Deltamune & Vaxxinova Join Forces

The Netherlands, July 9, 2025 – Today we are pleased to announce the acquisition of Deltamune (Pty) Ltd (South Africa) from Phatisa.
Deltamune is a leading Animal Health company in South Africa, specialized in African livestock solutions with in-house R&D and production capabilities for licensed and autogenous vaccines, covering Sub Saharan Africa.
Phatisa is a respected African private equity firm with a passion to positively impact the lives and livelihoods of African people.
With Deltamune now part of the Vaxxinova group, our expertise network will cover all continents. This allows us to respond fast to emerging diseases, continue to develop the right products for the future and to support fast exchange of expertise where relevant.

Read the full press release here